Form 4 holding
Director, Other*, 10%+ Owner
Atara Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,209,395
- Estimated value
- $7,994,100
- Report date
- 16 May 2025
- Price
- $6.61
- Ownership
- Direct
Adiumentum Capital Fund I LP - Director, Other*, 10%+ Owner at Atara Biotherapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Company
- Role
- Director, Other*, 10%+ Owner
- Issuer Symbol
- ATRA on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Adiumentum Capital Fund I LP since 26 May 2025
Holdings reported by Adiumentum Capital Fund I LP for Atara Biotherapeutics, Inc.
Form 4 holding
Director, Other*, 10%+ Owner
Atara Biotherapeutics, Inc.
- Security class
- Warrants (right to buy)
- Shares / value
- 377,193
- Estimated value
- $2,493,208
- Report date
- 16 May 2025
- Price
- $6.61
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Adiumentum Capital Fund I LP for Atara Biotherapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.